Presentation is loading. Please wait.

Presentation is loading. Please wait.

L-NAME HCl L-NAMEL-NAME is a nonselective inhibitor of nitric oxide synthetases (NOS) for nNOS (bovine), eNOS (human), and iNOS (murine), with Ki of 15.

Published byBOC Sciences Modified over 7 years ago

Similar presentations

Presentation on theme: "L-NAME HCl L-NAMEL-NAME is a nonselective inhibitor of nitric oxide synthetases (NOS) for nNOS (bovine), eNOS (human), and iNOS (murine), with Ki of 15."— Presentation transcript:

1 L-NAME HCl L-NAMEL-NAME is a nonselective inhibitor of nitric oxide synthetases (NOS) for nNOS (bovine), eNOS (human), and iNOS (murine), with Ki of 15 nM, 39 nM and 4.4 μM, respectively.

Download ppt "L-NAME HCl L-NAMEL-NAME is a nonselective inhibitor of nitric oxide synthetases (NOS) for nNOS (bovine), eNOS (human), and iNOS (murine), with Ki of 15."

Similar presentations

1. Name the salt made when these react… Magnesium + sulfuric acid 

1. Name the salt made when these react… Magnesium + sulfuric acid 
A c i d s & B a s e s. A c i d - B a s e T h e o r i e s A r r h e n i u s B r o n s t e d - L o w r y L e w i s A r r h e n i u s B r o n s t e d - L.

A c i d s & B a s e s. A c i d - B a s e T h e o r i e s A r r h e n i u s B r o n s t e d - L o w r y L e w i s A r r h e n i u s B r o n s t e d - L.
 A  p q B  C D  r F G E t I J H s u K    P.

 A  p q B  C D  r F G E t I J H s u K    P.
Eaton Lab Innovation & Conventional patch clamping cell.

Eaton Lab Innovation & Conventional patch clamping cell.
PKG Signalling PDK1PKG T58 T516 ? PKC  cGMP. S1105 S23 PLCB3 T1122 PDE5A S106 GUCY1A3 S64 eNOS S1177 PDK1PKG T58 T516 ? PKC  cGMP PKG Signalling.

PKG Signalling PDK1PKG T58 T516 ? PKC  cGMP. S1105 S23 PLCB3 T1122 PDE5A S106 GUCY1A3 S64 eNOS S1177 PDK1PKG T58 T516 ? PKC  cGMP PKG Signalling.
CGMP-dependent Protein Kinase Signalling Pathways Produced by Dr. Steven Pelech Kinexus Bioinformatics Corporation Copyright 2010.

CGMP-dependent Protein Kinase Signalling Pathways Produced by Dr. Steven Pelech Kinexus Bioinformatics Corporation Copyright 2010.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Endothelial Nitric Oxide Synthase Overexpression.

Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Endothelial Nitric Oxide Synthase Overexpression.
Loratadine Loratadine is a histamine H1 receptor antagonist, used to treat allergies. Also acts as a selective inhibitor of B(0)AT2 with IC50 of 4 μM.

Loratadine Loratadine is a histamine H1 receptor antagonist, used to treat allergies. Also acts as a selective inhibitor of B(0)AT2 with IC50 of 4 μM.
Pravastatin sodium Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.

Pravastatin sodium Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.
Polymorphisms in endothelial nitric oxide synthase and atherogenesis

Polymorphisms in endothelial nitric oxide synthase and atherogenesis
Erythrocyte Nitric Oxide in Patients with glaucoma ex vivo study

Erythrocyte Nitric Oxide in Patients with glaucoma ex vivo study
Volume 65, Issue 6, Pages (June 2004)

Volume 65, Issue 6, Pages (June 2004)
Volume 117, Issue 1, Pages (July 1999)

Volume 117, Issue 1, Pages (July 1999)
Volume 85, Issue 2, Pages (January 2014)

Volume 85, Issue 2, Pages (January 2014)
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri  Kidney International 

Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri  Kidney International 
C.C. McGown, Z.L.S. Brookes  British Journal of Anaesthesia 

C.C. McGown, Z.L.S. Brookes  British Journal of Anaesthesia 
George D. Webb, PhD, Lay Har Lim, BSc, Vernon M. S

George D. Webb, PhD, Lay Har Lim, BSc, Vernon M. S
Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation.

Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation.
Volume 59, Issue 3, Pages (March 2001)

Volume 59, Issue 3, Pages (March 2001)

Similar presentations

Ads by Google